Ohcanbohtosat - Shivangi Joshi
- Čájehuvvo 1 - 3 / 3
-
1
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma Dahkki Andrew R. Conery, Richard C. Centore, Adrianne Neiss, Patricia J. Keller, Shivangi Joshi, Kerry L. Spillane, Péter Sandy, Charlie Hatton, Eneida Pardo, Laura E. Zawadzke, Archana Bommi‐Reddy, Karen E. Gascoigne, Barbara M. Bryant, Jennifer A. Mertz, Robert J. Sims
Almmustuhtton 2016Artigo -
2
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors Dahkki Michele Ceribelli, Priscilla N. Kelly, Arthur L. Shaffer, George W. Wright, Wenming Xiao, Yibin Yang, Lesley A. Mathews Griner, Rajarshi Guha, Paul Shinn, Jonathan M. Keller, Dongbo Liu, Paresma Patel, Marc Ferrer, Shivangi Joshi, Sujata Nerle, Péter Sandy, Emmanuel Normant, Craig J. Thomas, Louis M. Staudt
Almmustuhtton 2014Artigo -
3
Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors Dahkki Victor Gehling, Michael C. Hewitt, Rishi G. Vaswani, Yves Leblanc, Alexandre Côté, Christopher G. Nasveschuk, Alexander M. Taylor, Jean-Christophe Harmange, James E. Audia, Eneida Pardo, Shivangi Joshi, Péter Sandy, Jennifer A. Mertz, Robert J. Sims, Louise Bergeron, Barbara M. Bryant, S.F. Bellon, Florence Poy, Hariharan Jayaram, Ravichandran Sankaranarayanan, Sreegouri Yellapantula, Nandana Bangalore Srinivasamurthy, Swarnakumari Birudukota, Brian K. Albrecht
Almmustuhtton 2013Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Biochemistry
Bromodomain
Cancer research
Cell biology
Gene
Genetics
Acetylation
Azepine
BRD4
Biomedical engineering
Bruton's tyrosine kinase
Chemistry
Chronic lymphocytic leukemia
Computational biology
Diffuse large B-cell lymphoma
Drug discovery
Epigenetics
IRF4
Ibrutinib
Immunology
In vivo
Isoxazole
Kinase
Leukemia
Lymphoma
Medicine
Modularity (biology)
Scaffold
Signal transduction